Crossmark

Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk

Crossref DOI link: https://doi.org/10.1007/s10549-026-08020-5

Published Online: 2026-07-10

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Comeaux, Jacob G. https://orcid.org/0000-0002-0944-5079
Gutierrez, Natalia

Ricker, Charité N. https://orcid.org/0000-0002-0620-9345
Nie, Qi https://orcid.org/0009-0005-1165-7782
Nguyen, Averi

Garcia, Ivan

Chang, Emmeline Y.

Waggoner, Rebecca M.

Groshen, Susan

Lerman, Caryn

Spicer, Darcy

Culver, Julie O. https://orcid.org/0000-0001-8658-3507
Funding

Funding for this research was provided by:

University of Southern California
License Information

Text and Data Mining valid from 2026-07-01

Version of Record valid from 2026-07-10
More Information

Article History

Received: 19 December 2025

Accepted: 20 June 2026

First Online: 10 July 2026

Declarations

Ethics approval: This study was approved by the Institutional Review Board of the University of Southern California.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below